ERVW-1 and infection: - therapeutic vaccination with Ad26-based (expressing SIVsmE543 gag-pol, HIV-1 mosaic-1 env, and HIV-1 mosaic-2 env) and MVA-based (expressing SIVsmE543 gag-pol, HIV-1 mosaic-1 env-gag-pol, and HIV-1 mosaic-2 env-gag-pol) vaccines with bNAb PGT101 and TLR7 agonist GS-9620 - study included Indian-origin rhesus macaques infected with SHIV-SF162P3 (ART initiation at day 9 following infection)